These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12569164)

  • 1. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis.
    Moshous D; Pannetier C; Chasseval Rd Rd; Deist Fl Fl; Cavazzana-Calvo M; Romana S; Macintyre E; Canioni D; Brousse N; Fischer A; Casanova JL; Villartay JP
    J Clin Invest; 2003 Feb; 111(3):381-7. PubMed ID: 12569164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
    Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
    Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-PKcs deficiency in human: long predicted, finally found.
    van der Burg M; van Dongen JJ; van Gent DC
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):503-9. PubMed ID: 19823081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemis splice defects cause atypical SCID and can be restored in vitro by an antisense oligonucleotide.
    Ijspeert H; Lankester AC; van den Berg JM; Wiegant W; van Zelm MC; Weemaes CM; Warris A; Pan-Hammarström Q; Pastink A; van Tol MJ; van Dongen JJ; van Gent DC; van der Burg M
    Genes Immun; 2011 Sep; 12(6):434-44. PubMed ID: 21390052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemis, a novel guardian of the genome.
    Dudásová Z; Chovanec M
    Neoplasma; 2003; 50(5):311-8. PubMed ID: 14628082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.
    Moshous D; Callebaut I; de Chasseval R; Corneo B; Cavazzana-Calvo M; Le Deist F; Tezcan I; Sanal O; Bertrand Y; Philippe N; Fischer A; de Villartay JP
    Cell; 2001 Apr; 105(2):177-86. PubMed ID: 11336668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.
    Buck D; Moshous D; de Chasseval R; Ma Y; le Deist F; Cavazzana-Calvo M; Fischer A; Casanova JL; Lieber MR; de Villartay JP
    Eur J Immunol; 2006 Jan; 36(1):224-35. PubMed ID: 16358361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
    Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
    Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
    Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
    Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.
    Jacobs C; Huang Y; Masud T; Lu W; Westfield G; Giblin W; Sekiguchi JM
    Hum Mol Genet; 2011 Feb; 20(4):806-19. PubMed ID: 21147755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omenn syndrome due to ARTEMIS mutations.
    Ege M; Ma Y; Manfras B; Kalwak K; Lu H; Lieber MR; Schwarz K; Pannicke U
    Blood; 2005 Jun; 105(11):4179-86. PubMed ID: 15731174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immunoglobulin class switch recombination in the absence of Artemis.
    Rivera-Munoz P; Soulas-Sprauel P; Le Guyader G; Abramowski V; Bruneau S; Fischer A; Pâques F; de Villartay JP
    Blood; 2009 Oct; 114(17):3601-9. PubMed ID: 19692705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.
    van der Burg M; van Veelen LR; Verkaik NS; Wiegant WW; Hartwig NG; Barendregt BH; Brugmans L; Raams A; Jaspers NG; Zdzienicka MZ; van Dongen JJ; van Gent DC
    J Clin Invest; 2006 Jan; 116(1):137-45. PubMed ID: 16357942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
    Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
    Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leaky Scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice.
    Rooney S; Sekiguchi J; Zhu C; Cheng HL; Manis J; Whitlow S; DeVido J; Foy D; Chaudhuri J; Lombard D; Alt FW
    Mol Cell; 2002 Dec; 10(6):1379-90. PubMed ID: 12504013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
    Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
    Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.
    van der Burg M; Ijspeert H; Verkaik NS; Turul T; Wiegant WW; Morotomi-Yano K; Mari PO; Tezcan I; Chen DJ; Zdzienicka MZ; van Dongen JJ; van Gent DC
    J Clin Invest; 2009 Jan; 119(1):91-8. PubMed ID: 19075392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a hypomorphic Artemis disease allele on lymphocyte development, DNA end processing, and genome stability.
    Huang Y; Giblin W; Kubec M; Westfield G; St Charles J; Chadde L; Kraftson S; Sekiguchi J
    J Exp Med; 2009 Apr; 206(4):893-908. PubMed ID: 19349461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.